Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Dr. Tommy Leonard | President Director | 1986 |
| Engineer Siu Pen Mok | Finance & Administration Director and Director | 1965 |
| Kalung Chandra S.E. | Head of Internal Audit Unit | NA |
| Ms. Maya Tirani | Corporate Secretary | 1984 |
PRIM
Royal Prima PT
ISIN
ID1000143209
Employees
797
Phone
62 21 2902 1997
Fiscal year end
December
Address
Gedung Grand Slipi Tower, Jakarta, Indonesia, 11480
123.00
-1.00 (-0.81%)
IDR · JK
52-week range
64.00
134.00
Trading at 84% of the 52-week range
Market Cap
412.16B
P/E Ratio
0.00
Forward P/E
0.00
Book Value
277.39
Div. Yield
N/A
% Institutions
0.781%
% Insiders
78.08%
1 Year
+55.0%3 Year
+33.3%10 Year
-85.6%Description
PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical oncology, plastic surgery, pediatric surgery, neurosurgery, digestive surgery, dermatologist and venereologist, psychiatric, dental polyclinic, oral surgery, vascular surgery, kidney and hypertension, endocrine metabolic diabetes. The company was founded in 2013 and is based in Jakarta, Indonesia.
Actions
Add an action for PRIM.JK, or sign in to see your action list.
People
Financial Highlights
Market Cap:
$412.16B
EBITDA:
$32.73B
Book Value:
$277.39
Earnings/Share:
$-5.64
Profit Margin:
-5.96%
Operating Margin:
1.63%
ROA (TTM):
-1.27%
ROE (TTM):
-2.02%
Revenue (TTM):
$320.78B
Revenue/Share (TTM):
$94.95
Earnings Growth (YOY):
23.30%
Revenue Growth (YOY):
-10.60%
Valuation Metrics
Enterprise Value:
$393.81B
Trailing P/E:
0.00
Forward P/E:
0.00
Shares Statistics
Shares Outstanding:
3.38B
Shares Float:
729.38M
% Insiders:
78.08%
% Institutions:
0.781%
Stock Price History
1 Year Price History
3 Years Price History
10 Years Price History
Max Price History
Financial Charts
Revenue, Net Income & Operating Cash Flow (Yearly)
Change % vs Prior Year
Revenue, Net Income & Operating Cash Flow (Quarterly)
Change % vs Prior Quarter
Operating Expenses (Yearly)
Operating Expenses (Quarterly)
Balance Sheet (Yearly)
Balance Sheet (Quarterly)
Assets Breakdown (Yearly)
Assets Breakdown (Quarterly)
Liabilities Breakdown (Yearly)
Liabilities Breakdown (Quarterly)
Income Statement Waterfall
Line Item
Step Type
Value
Revenue
adjust
$338.91B
Cost of Goods Sold
adjust
$-270.69B
Gross Profit
subtotal
$68.22B
SG&A
adjust
$-38.72B
Other Operating Expense
adjust
$-52.41B
Operating Income
subtotal
$-22.91B
Other / Non-Operating Items
adjust
$1.09B
Net Income
subtotal
$-21.82B
Earnings Per Share (EPS) History
Financial Ratios
📦 Raw API Data (JSON Explorer)
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.